Alembic Pharmaceuticals today said no observations were issued by US health regulator USFDA after inspection of its Baroda facility. The bioequivalence facility was inspected by US Food & Drug Administration (USFDA) from March 6-10; March 13-17 and April 10-12, Alembic said in a filing to BSE. "There were no 483s issued by USFDA at the end of the inspection," it added.
We’re the advisory works only for you so let us work with you and we will help you grow your more in which way you want to click here to accept our invitation >> http://www.ripplesadvisory.com/free-trial.php
Alembic Pharmaceuticals today said no observations were issued by US health regulator USFDA after inspection of its Baroda facility. The bioequivalence facility was inspected by US Food & Drug Administration (USFDA) from March 6-10; March 13-17 and April 10-12, Alembic said in a filing to BSE. "There were no 483s issued by USFDA at the end of the inspection," it added.
No comments:
Post a Comment